BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 24924975)

  • 1. Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis.
    Miljkovic D; Bassiouni A; Cooksley C; Ou J; Hauben E; Wormald PJ; Vreugde S
    Allergy; 2014 Sep; 69(9):1154-61. PubMed ID: 24924975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia.
    Ho J; Bailey M; Zaunders J; Mrad N; Sacks R; Sewell W; Harvey RJ
    Clin Exp Allergy; 2015 Feb; 45(2):394-403. PubMed ID: 25429730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.
    Shin HW; Kim DK; Park MH; Eun KM; Lee M; So D; Kong IG; Mo JH; Yang MS; Jin HR; Park JW; Kim DW
    J Allergy Clin Immunol; 2015 Jun; 135(6):1476-85.e7. PubMed ID: 25725991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of type 2 innate lymphoid cells in the pathogenesis of eosinophilic chronic rhinosinusitis with nasal polyps].
    Geng CL; Xing ZM; Yu LS; Wang M; Yuan XP; Liu Y; Zhang G; Wang ZJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):369-374. PubMed ID: 29764019
    [No Abstract]   [Full Text] [Related]  

  • 5. Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps.
    Poposki JA; Klingler AI; Tan BK; Soroosh P; Banie H; Lewis G; Hulse KE; Stevens WW; Peters AT; Grammer LC; Schleimer RP; Welch KC; Smith SS; Conley DB; Raviv JR; Karras JG; Akbari O; Kern RC; Kato A
    Immun Inflamm Dis; 2017 Sep; 5(3):233-243. PubMed ID: 28474861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proallergic cytokines and group 2 innate lymphoid cells in allergic nasal diseases.
    Matsushita K; Kato Y; Akasaki S; Yoshimoto T
    Allergol Int; 2015 Jul; 64(3):235-40. PubMed ID: 26117254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antimicrobial protein short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is differentially modulated in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps.
    Wei Y; Xia W; Ye X; Fan Y; Shi J; Wen W; Yang P; Li H;
    J Allergy Clin Immunol; 2014 Feb; 133(2):420-8. PubMed ID: 24342548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular comparison of sinus mucosa vs polyp tissue from a single sinus cavity in chronic rhinosinusitis.
    Ho J; Bailey M; Zaunders J; Mrad N; Sacks R; Sewell W; Harvey RJ
    Int Forum Allergy Rhinol; 2015 Jan; 5(1):14-27. PubMed ID: 25332132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group 2 innate lymphoid cells are increased in nasal polyps in patients with eosinophilic chronic rhinosinusitis.
    Tojima I; Kouzaki H; Shimizu S; Ogawa T; Arikata M; Kita H; Shimizu T
    Clin Immunol; 2016 Sep; 170():1-8. PubMed ID: 27422491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps.
    Ogasawara N; Poposki JA; Klingler AI; Tan BK; Hulse KE; Stevens WW; Peters AT; Grammer LC; Welch KC; Smith SS; Conley DB; Raviv JR; Soroosh P; Takano KI; Himi T; Kern RC; Schleimer RP; Kato A
    Mucosal Immunol; 2020 Jan; 13(1):86-95. PubMed ID: 31641233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group 2 innate lymphoid cells and eosinophilic chronic rhinosinusitis.
    Tojima I; Shimizu T
    Curr Opin Allergy Clin Immunol; 2019 Feb; 19(1):18-25. PubMed ID: 30507713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps.
    Shaw JL; Fakhri S; Citardi MJ; Porter PC; Corry DB; Kheradmand F; Liu YJ; Luong A
    Am J Respir Crit Care Med; 2013 Aug; 188(4):432-9. PubMed ID: 23805875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal biomarker profiles in acute and chronic rhinosinusitis.
    Riechelmann H; Deutschle T; Rozsasi A; Keck T; Polzehl D; Bürner H
    Clin Exp Allergy; 2005 Sep; 35(9):1186-91. PubMed ID: 16164446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of adhesion molecules by sinonasal fibroblasts among control and chronic rhinosinusitis patients.
    Oyer SL; Nagel W; Mulligan JK
    Am J Rhinol Allergy; 2013; 27(5):381-6. PubMed ID: 24119601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Allergic Rhinitis in Chronic Rhinosinusitis.
    Helman SN; Barrow E; Edwards T; DelGaudio JM; Levy JM; Wise SK
    Immunol Allergy Clin North Am; 2020 May; 40(2):201-214. PubMed ID: 32278445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Type 2 innate lymphoid cells and chronic rhinosinusitis].
    Geng CL; Xing ZM
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):585-588. PubMed ID: 29871081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4(+) and CD8(+) regulatory T cells in chronic rhinosinusitis mucosa.
    Pant H; Hughes A; Schembri M; Miljkovic D; Krumbiegel D
    Am J Rhinol Allergy; 2014; 28(2):e83-9. PubMed ID: 24717938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic monocyte-derived dendritic cells and associated Th2 skewing in chronic rhinosinusitis.
    O'Connell BP; Schlosser RJ; Wentzel JL; Nagel W; Mulligan JK
    Otolaryngol Head Neck Surg; 2014 Feb; 150(2):312-20. PubMed ID: 24367054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting IL-25 as a novel therapy in chronic rhinosinusitis with nasal polyps.
    Lee M; Kim DW; Shin HW
    Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):17-22. PubMed ID: 27870664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group 2 innate lymphoid cells in nasal polyposis.
    Stevens WW; Kato A
    Ann Allergy Asthma Immunol; 2021 Feb; 126(2):110-117. PubMed ID: 32781240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.